Efficacy and tolerability of dolutegravir and two nucleos(t)ide reverse transcriptase inhibitors in HIV-1-positive, virologically suppressed patients

AIDS. 2017 Jan 28;31(3):457-459. doi: 10.1097/QAD.0000000000001357.

¹ aInstitute of Clinical Infectious Diseases, Catholic University of Sacred Heart, Policlinico Gemelli, Rome bDivision of Infectious Diseases, Department of Infectious Diseases, Luigi Sacco University Hospital, Milan cDivision of Tropical and Infectious Diseases, 'Careggi' Hospital, Florence dInfectious Diseases Unit, DIBIC Luigi Sacco, University of Milan, Milan eInfectious Dermatology and Allergology Unit, IFO S. Gallicano Institute (IRCCS), Rome fInstitute of Infectious Diseases and Public Health, Università Politecnica delle Marche, Ancona gDepartment of Clinical and Experimental Medicine, University of Sassari, Sassari hUniversity Division of Infectious Diseases, Siena University Hospital, Siena, Italy.

No abstract available

Publication types